Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Align Technology | 15 | 2 | 0 | 0 | €251.70 | €345.95 | 37.445% |
| Adverum Biotechnologies Inc. | 6 | 1 | 0 | 0 | €1.38 | €4.66 | 237.768% |
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.70 | €17.21 | 47.116% |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.70 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €68.66 | €100.00 | 45.645% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.61 | €3.70 | 130.100% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €121.00 | €124.93 | 3.247% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Abbott Laboratories | 16 | 0 | 0 | 0 | €97.49 | €116.81 | 19.815% |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €23.80 | €32.18 | 35.219% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.45 | €8.27 | 28.260% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €114.85 | €147.62 | 28.529% |
| PTC Therapeutics Inc. | 14 | 5 | 0 | 0 | €28.20 | €41.51 | 47.207% |
| Cara Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.69 | €4.63 | 570.913% |
| Akebia Therapeutics Inc. | 8 | 3 | 0 | 0 | €1.19 | €3.60 | 202.955% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.47 | - | - |
| Abeona Therapeutics Inc. | 3 | 1 | 0 | 0 | €3.92 | €34.41 | 777.872% |
| Agilent Technologies Inc. | 17 | 3 | 0 | 0 | €138.88 | €134.50 | -3.152% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €336.80 | €369.72 | 9.776% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 0 | €4.78 | €12.80 | 167.814% |
| Atossa Genetics Inc | 5 | 1 | 0 | 0 | €1.39 | €3.72 | 168.283% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.92 | €11.05 | 181.847% |
| Davita Inc. | 2 | 0 | 0 | 0 | €127.90 | €124.89 | -2.355% |
| Intuitive Surgical Inc | 34 | 0 | 0 | 0 | €358.30 | €376.15 | 4.982% |